Hafkin, B., Kaplan, N., & Murphy, B. (2016). Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities. Antimicrob Agents Chemother.
Citação norma ChicagoHafkin, B., N. Kaplan, and B. Murphy. "Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients With Significant Comorbidities." Antimicrob Agents Chemother 2016.
MLA引文Hafkin, B., N. Kaplan, and B. Murphy. "Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients With Significant Comorbidities." Antimicrob Agents Chemother 2016.